Direkt zum Inhalt
Merck

Role of Aberrant Spontaneous Neurotransmission in SNAP25-Associated Encephalopathies.

Neuron (2020-11-05)
Baris Alten, Qiangjun Zhou, Ok-Ho Shin, Luis Esquivies, Pei-Yi Lin, K Ian White, Rong Sun, Wendy K Chung, Lisa M Monteggia, Axel T Brunger, Ege T Kavalali
ZUSAMMENFASSUNG

SNARE (soluble N-ethylmaleimide sensitive factor attachment protein receptor) complex, composed of synaptobrevin, syntaxin, and SNAP25, forms the essential fusion machinery for neurotransmitter release. Recent studies have reported several mutations in the gene encoding SNAP25 as a causative factor for developmental and epileptic encephalopathies of infancy and childhood with diverse clinical manifestations. However, it remains unclear how SNAP25 mutations give rise to these disorders. Here, we show that although structurally clustered mutations in SNAP25 give rise to related synaptic transmission phenotypes, specific alterations in spontaneous neurotransmitter release are a key factor to account for disease heterogeneity. Importantly, we identified a single mutation that augments spontaneous release without altering evoked release, suggesting that aberrant spontaneous release is sufficient to cause disease in humans.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Lysozym aus Hühnereiweiss, powder or granules, ≥39,000 units/mg protein
Sigma-Aldrich
Deoxyribonuclease I aus Rinderpankreas, Type IV, lyophilized powder, ≥2,000 Kunitz units/mg protein
Sigma-Aldrich
Anti-vesikulärer Glutamattransporter 1-Antikörper, serum, Chemicon®
Sigma-Aldrich
Cytosin β-D-Arabinofuranosid -hydrochlorid, crystalline
Sigma-Aldrich
Picrotoxin, powder
Sigma-Aldrich
CNQX Dinatriumsalz Hydrat, ≥98% (HPLC), solid
Sigma-Aldrich
D(−)-2-Amino-5-phosphonopentansäure, NMDA receptor antagonist
Sigma-Aldrich
CNQX, ≥98% (HPLC), solid